Company: SYRA
Filing Date: 2025-03-11
Form Type: 10-K
Source: 0001493152-25-009873
Chunk: 493

Company: Syra Health Corp
Filing Date: 2025-03-11
Form: 10-K
Item: Item 2
Chunk 493
---
 Form 10-K does not include an attestation report of our independent registered public accounting firm regarding internal
control over financial reporting. Management’s report was not subject to attestation by the Company’s registered public accounting
firm pursuant to the exemption provided to issuers that are not “large accelerated filers” nor “accelerated filers”
under the Dodd-Frank Wall Street Reform and Consumer Protection Act as well as issuers that are “emerging growth companies”
under the JOBS Act.

-35-

Changes
in Internal Control Over Financial Reporting

There
were no changes in our internal control over financial reporting that occurred during the year ended December 31, 2024 that have materially
affected, or are reasonably likely to materially affect, our internal control over financial reporting.

ITEM
9B. OTHER INFORMATION

During
the quarter ended December 31, 2024, none of our directors or executive officers adopted, modified, or terminated a “Rule 10b5-1
trading arrangement” or a “non-Rule 10b5-1 trading arrangement” as such terms are defined under Rule 408 of Regulation
S-K.

ITEM
9C. DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS.

Not
applicable.

PART
III

ITEM
10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE

The
information required by this item is incorporated by reference from the information contained in our Definitive Proxy Statement to be
filed with the Securities and Exchange Commission in connection with the Annual Meeting of Stockholders to be held in 2025 (the “2025
Proxy Statement”), under the heading “Election of Directors.”

ITEM
11. EXECUTIVE COMPENSATION

The
information required by this item is incorporated by reference from the information contained in the 2025 Proxy Statement under the heading
“Executive Compensation.”

ITEM
12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS

The
information required by this item is incorporated by reference from the information contained in the 2025 Proxy Statement under the headings
“Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.”

ITEM
13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE

The
information required by this item is incorporated by reference from the information contained in the 2025 Proxy Statement under the headings